Clinical trial shows that delaying treatment for localized prostate cancer does not increase mortality risk. Active monitoring of prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery, reports the largest study of its kind. The latest findings from the Prot
The largest study of its kind reports that active monitoring for prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery. Men on active monitoring were more likely to see the cancer progress or spread than those receiving radiotherapy or surgery, but this did not affect their survival rate. The study also found that the negative impacts of radiotherapy and surgery on urinary and sexual function last much longer than previously believed, up to 12 years.
The latest findings from the ProtecT trial, led by the Universities of Oxford and Bristol, were presented on March 11 at the European Association of Urology Congress in Milan and published in theThe trial was funded by the National Institute for Health and Care Research . The findings show that treatment decisions following diagnosis for low and intermediate-risk localized prostate cancer do not need to be rushed, according to lead investigator, Professor Freddie Hamdy from the“It’s clear that, unlike many other cancers, a diagnosis of prostate cancer should not be a cause for panic or rushed decision-making,” he said.
They found that around 97% of the men diagnosed with prostate cancer survived 15 years after diagnosis, irrespective of which treatment they received. Around a quarter of the men on active monitoring had still not had any invasive treatment for their cancer after 15 years. Professor Freddie Hamdy said: “This is very good news. Most men with localized prostate cancer are likely to live for a long time, whether or not they receive invasive treatment and whether or not their disease has spread, so a quick decision for treatment is not necessary and could cause harm.”
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
UK study shows prostate cancer treatment can wait for most menResearchers have found long-term evidence that actively monitoring localized prostate cancer is a safe alternative to immediate surgery or radiation.
Consulte Mais informação »
Men With Prostate Cancer Can Thrive for Years With Less Aggressive TreatmentMen with low-grade and some with moderate-grade localized prostate cancer could safely choose surveillance over surgery or radiation, according to a newly published study.
Consulte Mais informação »
Prostate cancer treatment can wait for most men, study findsA study finds long-term evidence that actively monitoring localized prostate cancer can be a safe alternative to immediate surgery or radiation
Consulte Mais informação »
Prostate cancer treatment can wait for most men, study findsResearchers have found long-term evidence that actively monitoring localized prostate cancer is a safe alternative to immediate surgery or radiation. The results, released Saturday, are encouraging for men who want to avoid treatment-related sexual and incontinence problems, said Dr.
Consulte Mais informação »
Prostate cancer treatment can wait for most men, study findsA study finds long-term evidence that actively monitoring localized prostate cancer can be a safe alternative to immediate surgery or radiation.
Consulte Mais informação »